ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 245 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $631,000 | -33.6% | 38,000 | -2.6% | 0.07% | -32.3% |
| Q2 2021 | $951,000 | -5.5% | 39,000 | 0.0% | 0.10% | -11.6% |
| Q1 2021 | $1,006,000 | -51.8% | 39,000 | 0.0% | 0.11% | -55.9% |
| Q4 2020 | $2,085,000 | +29.6% | 39,000 | 0.0% | 0.25% | +4.5% |
| Q3 2020 | $1,609,000 | -14.9% | 39,000 | 0.0% | 0.24% | -33.2% |
| Q2 2020 | $1,890,000 | +14.7% | 39,000 | 0.0% | 0.36% | -0.8% |
| Q1 2020 | $1,648,000 | -1.2% | 39,000 | 0.0% | 0.37% | +15.8% |
| Q4 2019 | $1,668,000 | +18.8% | 39,000 | 0.0% | 0.32% | +22.4% |
| Q3 2019 | $1,404,000 | +7.2% | 39,000 | -20.4% | 0.26% | -4.8% |
| Q2 2019 | $1,310,000 | -14.4% | 49,000 | -14.0% | 0.27% | -18.3% |
| Q1 2019 | $1,530,000 | +65.9% | 57,000 | -0.0% | 0.33% | +50.7% |
| Q4 2018 | $922,000 | -22.1% | 57,010 | 0.0% | 0.22% | -9.1% |
| Q3 2018 | $1,184,000 | +149.8% | 57,010 | +83.8% | 0.24% | +135.9% |
| Q2 2018 | $474,000 | -18.8% | 31,010 | +19.3% | 0.10% | +232.3% |
| Q1 2018 | $584,000 | -7.6% | 26,000 | +23.8% | 0.03% | -3.1% |
| Q4 2017 | $632,000 | +52.7% | 21,000 | +90.9% | 0.03% | +52.4% |
| Q3 2017 | $414,000 | – | 11,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 25,819,768 | $972,631,000 | 7.89% |
| SECTORAL ASSET MANAGEMENT INC | 822,392 | $30,980,000 | 3.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 240,773 | $9,068,000 | 3.53% |
| HARVEY CAPITAL MANAGEMENT INC | 230,700 | $8,690,000 | 3.51% |
| Palo Alto Investors LP | 1,641,030 | $61,818,000 | 2.60% |
| GARRISON BRADFORD & ASSOCIATES INC | 73,350 | $2,763,000 | 2.31% |
| EMORY UNIVERSITY | 52,977 | $1,996,000 | 1.58% |
| Sivik Global Healthcare LLC | 120,000 | $4,520,000 | 1.54% |
| Stanley-Laman Group, Ltd. | 143,876 | $5,420,000 | 1.45% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $6,404,000 | 1.15% |